Oral administration of a new soluble branched β-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers

Author:

Lehne G1,Haneberg B2,Gaustad P3,Johansen P W1,Preus H4,Abrahamsen T G5

Affiliation:

1. Clinical Research Unit

2. Norwegian Institute of Public Health, Oslo

3. Institute of Microbiology

4. Department of Periodontology, Faculty of Dentistry, University of Oslo, Norway

5. Department of Paediatrics, Rikshospitalet-Radiumhospitalet Trust, Oslo

Abstract

Summary The soluble branched yeast β-1,3-D-glucan (SBG) belongs to a group of carbohydrate polymers known to exert potent immunomodulatory effects when administered to animals and humans. A new oral solution of SBG has been developed for local application to the oropharyngeal and oesophageal mucosa in order to strengthen the defence mechanisms against microbial and toxic influences. In the present study oral administration of SBG has been investigated primarily for assessment of safety and tolerability in an early phase human pharmacological study (phase I). Eighteen healthy volunteers were included among non-smoking individuals. The study was an open 1 : 1 : 1 dose-escalation safety study consisting of a screening visit, an administration period of 4 days and a follow-up period. Groups of six individuals received SBG 100 mg/day, 200 mg/day or 400 mg/day, respectively, for 4 consecutive days. The dose increase was allowed after a careful review of the safety data of the lower dose group. No drug-related adverse event, including abnormalities in vital signs, was observed. By inspection of the oral cavity only minor mucosal lesions not related to the study medication were seen in seven subjects. Repeated measurements of β-glucan in serum revealed no systemic absorption of the agent following the oral doses of SBG. In saliva, the immunoglobulin A concentration increased significantly for the highest SBG dose employed. SBG was thus safe and well tolerated by healthy volunteers, when given orally once daily for 4 consecutive days at doses up to 400 mg.

Publisher

Oxford University Press (OUP)

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Overview of (1–3)-beta-D-glucan immunobiology;Williams;Med Inflamm,1997

2. Immunomodulators − medicine for the 90-ies?;Seljelid,1990

3. Effect of structurally different beta-glucans on immune responses in Atlantic salmon;Engstad;J Mar Biotech,1995

4. (1–3)-beta-D-glucans as biologigal response modifiers: a review of structure–function relationships;Bohn;Carbohydr Polym,1995

5. Dectin-1 mediates the biological effects of beta-glucans;Brown;J Exp Med,2003

Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3